MAP2K7 and glioblastoma: This has already been demonstrated for glioblastoma cells, where reactivating FNMA by dexamethasone, the MEK-inhibitor PD98059, or the benzoquinone ansamycin antibiotic Geldanamycin, led to a significant increase in aggregate cohesion and reduced aggregate dispersal velocity [3].